MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the year ending 2025-12-31.

Cash Flow Overview

Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from atm sales of commo...
    • Share based compensation
    • Accounts payable and accrued exp...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accounts payable and accrued exp...
    • Change in fair value of warrant ...
    • Gain on repurchase of common sto...

Cash Flow
2025-12-31
Net loss
-2,947
Share based compensation
665
Loss on common stock warrant liabilities
0
Change in fair value of warrant liability
-15
Issuance of stock under founders agreement
76
Common stock, issued to fortress, value
55
License expenses paid in kind
0
Gain on repurchase of common stock held by annji
4
Issuance of common stock of subsidiary
37
Prepaid expenses and other current assets
-2
Accounts payable and accrued expenses-Nonrelated Party
-186
Accounts payable and accrued expenses-Related Party
484
Net cash and cash equivalents used in operating activities
-1,833
Proceeds from atm sales of common stock, net of issuance costs
2,094
Proceeds from exercise of warrants
0
Warrant exercise transaction costs
0
Net cash provided by financing activities
2,094
Net change in cash and cash equivalents
261
Cash and cash equivalents, beginning of period
2,594
Cash and cash equivalents, end of period
2,855
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from atm sales ofcommon stock, net of...$2,094K Net cash provided byfinancing activities$2,094K Net change in cashand cash...$261K Canceled cashflow$1,833K Share basedcompensation$665K Accounts payable andaccrued...$484K Issuance of stock underfounders agreement$76K Common stock, issued tofortress, value$55K Issuance of common stockof subsidiary$37K Prepaid expenses andother current assets-$2K Net cash and cashequivalents used in...-$1,833K Canceled cashflow$1,319K Net loss-$2,947K Accounts payable andaccrued...-$186K Change in fair value ofwarrant liability-$15K Gain on repurchase ofcommon stock held by...$4K

AVENUE THERAPEUTICS, INC. (ATXI)

AVENUE THERAPEUTICS, INC. (ATXI)